Preliminary Results Of Ucart19, An Allogeneic Anti-Cd19 Car T-Cell Product, In A First-In-Human Trial (Calm) In Adult Patients With Cd19(+) Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

BLOOD(2017)

引用 7|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要